Delivery Order SPE2DB20D3303-SPE2DB25FA3NT
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,881.19 delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 21, 2025, with ultimate completion by August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract utilizing competitively-awarded pricing. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Crexont ER 52.5 mg–210 mg capsules (120-count) valued at $3,309.28. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a competitively awarded non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The award was performed at AmerisourceBergen's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.63 to AmerisourceBergen Drug Corp for Crexont ER 70 MG-280 MG capsules (120-count supply) on August 4, 2025, with completion scheduled for August 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,614.19 delivery order to AmerisourceBergen Drug Corp for CREXONT ER 52.5 mg-210 mg capsules (120-count) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price, non-set-aside contract represents a direct procurement of pharmaceutical products to support federal medical supply needs. The award was performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,192.05 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 mg-350 mg capsules (120-count supply). This is a firm fixed-price delivery order with no set-aside designation, completed on September 3, 2025, and performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,064.88, is for the supply of 120 capsules of the medication CREXONT ER 87.5 MG-350 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,681.17 contract is for the delivery of CREXONT ER 52.5 MG-210 MG CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...